
NRx Pharmaceuticals Clinches $5M Milestone Achievement for Breakthrough in Bipolar Depression Treatments
WILMINGTON, DE — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a pivotal player within the healthcare industry, this week announced a significant milestone in their ongoing quest to combat suicidal bipolar depression. …
NRx Pharmaceuticals Clinches $5M Milestone Achievement for Breakthrough in Bipolar Depression Treatments Read More